Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - Edesa Biotech, Inc.tm218114d1_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Edesa Biotech, Inc.tm218114d1_ex99-1.htm
EX-4.1 - EXHIBIT 4.1 - Edesa Biotech, Inc.tm218114d1_ex4-1.htm
EX-1.1 - EXHIBIT 1.1 - Edesa Biotech, Inc.tm218114d1_ex1-1.htm
8-K/A - FORM 8-K/A - Edesa Biotech, Inc.tm218114d1_8k.htm

 

Exhibit 5.1

 

 

 

February 25, 2021  

 

Edesa Biotech, Inc.
100 Spy Court

Markham, ON L3R 5H6

Canada

 

Dear Sirs/Mesdames:

 

Re:Edesa Biotech, Inc. – Offering of Common Shares

 

We have acted as Canadian legal counsel to Edesa Biotech, Inc., a British Columbia corporation (the “Company”), in connection with a offering (the “Offering”) of 1,796,875 common shares of the Company, no par value (“Common Stock”) (including 234,375 shares of Common Stock issuable by the Company upon exercise of an option to purchase additional shares granted by the Company to the underwriter) at a price per share of $6.40 pursuant to a prospectus supplement dated February 25, 2021 filed by the Company with the United States Securities and Exchange Commission (“SEC”) on February 25, 2021 (the “Prospectus Supplement”) pursuant to Rule 424(b) of the Securities Act of 1933, as amended (the “Act”), supplementing the Company’s existing shelf registration statement on Form S-3 (File No. 333-233567) filed by the Company with the SEC, which was declared effective by the SEC on September 12, 2019 (the “Registration Statement”) and the prospectus contained therein (the “Base Prospectus”, and together with the Prospectus Supplement, the “Prospectus”). The 1,796,875 shares of Common Stock issuable under the Registration Statement and Prospectus are hereinafter referred to as the “Offered Shares”.

 

The Offering is to be made pursuant to the terms of an amended and restated underwriting agreement (the “Underwriting Agreement”) dated February 25, 2021 between the Company and H.C. Wainwright & Co., LLC, as representative for the several underwriters named in the Underwriting Agreement (the “Underwriters”), pursuant to which the Company will sell, and the Underwriters will purchase, the Offered Shares.

 

We have reviewed and participated in the preparation of the Prospectus; and have reviewed, but not participated in the preparation of (i) the Registration Statement and (ii) the Underwriting Agreement.

 

 

 

2

 

We have examined originals or certified copies of such corporate records, documents, certificates and instruments as we have deemed relevant and necessary for the basis of our opinions hereinafter expressed. In such examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as duplicates or certified or conformed copies, and the authenticity of originals or such latter documents. As to various questions of fact material to such opinion that we have not independently established or verified, information with respect to which is in possession of the Company, we have relied upon certificates and other records and certificates of officers of the Corporation, including a certificate of an officer of the Company, dated the date hereof, certifying certain factual matters including, among other things: (i) the certificate of continuation, notice of articles and articles of the Company; (ii) the incumbency of certain officers of the Company; and (iii) resolutions passed by the directors of the Company approving, among other things, the execution, delivery and performance by the Company of its obligations under the Underwriting Agreement. In making our examination of executed documents or documents to be executed, we have assumed that the parties thereto, including the Company, had or will have the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and execution and delivery by such parties of such documents and, the validity and binding effect on all such parties.

 

In rendering our opinions set forth herein, we have also assumed that, at the time of the offer and sale of Offered Shares (i) the Company has been duly organized and is validly existing and in good standing, and has the requisite legal status and legal capacity, under the laws of the Province of British Columbia; (ii) the Company has complied and will comply with the laws of all relevant jurisdictions in connection with the transactions contemplated by, and the performance of its obligations under, the Registration Statement and the Underwriting Agreement; (iii) the Registration Statement and any amendments thereto (including any post-effective amendments thereto) has become effective under the Act; (iv) the Underwriting Agreement will have been duly authorized and validly executed and delivered by any party thereto other than the Company, and will be filed with the Commission on a Current Report on Form 8-K or other applicable periodic report in the manner contemplated in the Registration Statement and the Prospectus Supplement; and (v) that the Offered Shares have been issued and sold in compliance with applicable U.S. federal and state securities laws and in the manner stated in the Registration Statement, the Prospectus Supplement and the Underwriting Agreement. As to any facts material to our opinion, we have made no independent investigation of such facts and have relied, to the extent that we deem such reliance proper, upon certificates of public officials and officers or other representatives of the Company.

 

Based solely upon and subject to the foregoing, and subject to the assumptions, limitations, exceptions and qualifications stated herein, we are of the opinion that the Offered Shares, when issued and delivered against payment therefor in accordance with the terms of the Underwriting Agreement, with certificates representing such Offered Shares having been duly executed, countersigned, registered and delivered or, if uncertificated, valid book-entry notations therefor having been made in the central securities register of the Company, in accordance with the terms of the Underwriting Agreement, will be validly issued, fully paid and non-assessable.

 

The matters expressed in this letter are subject to and qualified and limited by (i) the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, arrangement, moratorium or other similar laws now or hereafter in effect relating to or affecting creditors’ rights generally; (ii) the effects of general equitable principles, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, and the possible unavailability of specific performance or injunctive relief, whether enforcement is considered in a proceeding in equity or law; (iii) the discretion of the court before which any proceeding for enforcement may be brought; and (iv) the unenforceability under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to the public policy. We express no opinion as to the sufficiency of any consideration to be paid for any Offered Shares or actual receipt of such consideration.

 

 

 

3

 

We are qualified to practice law in the Province of British Columbia, and we do not purport to be experts on the law of any other jurisdiction other than the Province of British Columbia and the federal laws of Canada applicable therein. We do not express any opinion herein concerning any law other than the laws of the Province of British Columbia and the federal laws of Canada applicable therein. We express no opinion and make no representation with respect to the law of any other jurisdiction. This opinion is expressed as of the date hereof unless otherwise expressly stated, and we disclaim any undertaking to advise you of any subsequent changes of the facts stated or assumed herein or any subsequent changes in applicable law.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and the use of our firm name where it appears in each of the Prospectus and the Prospectus Supplement under the caption “Legal Matters”. In giving this consent, we do not admit that we included in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations promulgated thereunder.

 

Yours truly,

 

FASKEN MARTINEAU DuMOULIN LLP